Tenofovir disoproxil fumarate/emtricitabine and severity of coronavirus disease 2019 in people with HIV infection
Discussion:
Compared with other antiretrovirals, TDF/FTC lowers COVID-19 severity among HIV-positive individuals with virological control. This protective effect may be restricted to individuals aged 50 years and older.
Source: AIDS - Category: Infectious Diseases Tags: Epidemiology and Social Source Type: research
More News: Coronavirus | COVID-19 | Epidemiology | HIV AIDS | Infectious Diseases | Intensive Care | Laboratory Medicine | Respiratory Medicine | SARS | Spain Health | Study | Truvada | Viread | Virology